Kayne Anderson Rudnick Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.76K Buy
17
+11
+183% +$4.08K ﹤0.01% 771
2026
Q1
$1.88K Sell
6
-697
-99% -$229K ﹤0.01% 796
2025
Q4
$247K Buy
703
+2
+0.3% +$676 ﹤0.01% 491
2025
Q3
$227K Sell
701
-13
-2% -$4.04K ﹤0.01% 494
2025
Q2
$278K Buy
714
+9
+1% +$3.62K ﹤0.01% 477
2025
Q1
$307K Hold
705
﹤0.01% 450
2024
Q4
$260K Sell
705
-4
-0.6% -$1.67K ﹤0.01% 441
2024
Q3
$369K Buy
709
+4
+0.6% +$2.14K ﹤0.01% 415
2024
Q2
$382K Buy
705
+3
+0.4% +$1.59K ﹤0.01% 428
2024
Q1
$364K Hold
702
﹤0.01% 430
2023
Q4
$331K Buy
702
+4
+0.6% +$1.85K ﹤0.01% 405
2023
Q3
$304K Hold
698
﹤0.01% 409
2023
Q2
$310K Buy
698
+4
+0.6% +$1.84K ﹤0.01% 408
2023
Q1
$319K Hold
694
﹤0.01% 396
2022
Q4
$356K Hold
694
﹤0.01% 401
2022
Q3
$315K Buy
694
+3
+0.4% +$1.44K ﹤0.01% 391
2022
Q2
$333K Sell
691
-11
-2% -$5.44K ﹤0.01% 388
2022
Q1
$345K Buy
702
+8
+1% +$3.66K ﹤0.01% 380
2021
Q4
$322K Buy
694
+3
+0.4% +$1.26K ﹤0.01% 390
2021
Q3
$258K Hold
691
﹤0.01% 389
2021
Q2
$264K Hold
691
﹤0.01% 386
2021
Q1
$248K Hold
691
﹤0.01% 386
2020
Q4
$222K Hold
691
﹤0.01% 376
2020
Q3
$186K Sell
691
-25
-3% -$6.73K ﹤0.01% 374
2020
Q2
$188K Hold
716
﹤0.01% 361
2020
Q1
$163K Sell
716
-3
-0.4% -$818 ﹤0.01% 354
2019
Q4
$217K Buy
719
+3
+0.4% +$826 ﹤0.01% 347
2019
Q3
$172K Buy
716
+691
+2,764% +$189K ﹤0.01% 347
2019
Q2
$7K Buy
+25
New +$6.83K ﹤0.01% 415

Other funds holding ELV

Kayne Anderson Rudnick Investment Management's ELV Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management increased its Elevance Health (ELV) stake by 183% in Q2 2026, buying an estimated $4.08K and bringing the position to 17 shares worth $6.76K. The position accounts for ﹤0.01% of the portfolio, ranked #771.

Kayne Anderson Rudnick Investment Management first reported a position in ELV in Q2 2019 and has held it in 29 quarters since. The position peaked at $382K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 17 shares of Elevance Health worth $6.76K as of Q2 2026.
  • Kayne Anderson Rudnick Investment Management bought 11 Elevance Health shares in Q2 2026, an estimated $4.08K.
  • Elevance Health made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #771 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Elevance Health in Q2 2019 and has held it in 29 quarters since.
  • Kayne Anderson Rudnick Investment Management's Elevance Health position peaked at $382K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.